Skip to main content
Log in

Adrenomedullin

Implications for Hypertension Research

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Regoli D, Cadieux A, D’Orleans-Juste P. Vasoactive peptides and their receptors. Methods Neurosci 1993; 11: 43–86.

    CAS  Google Scholar 

  2. Yanagisawa M. The endothelin system, a new target for therapeutic intervention. Circulation 1994; 89: 1320–2.

    Article  PubMed  CAS  Google Scholar 

  3. Anand-Srivastava MB, Trachte GJ. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 1933; 45: 455–97.

    Google Scholar 

  4. Kitamura K, Kangawa K, Kawamoto M, et al. Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma. Biochem Biophys Res Commun 1992; 185: 134–41.

    Article  PubMed  CAS  Google Scholar 

  5. Ichiki Y, Kitamura K, Kangawa K, et al. Organ distribution and characterization of peptides (VIP, CGRP and PHI) that increase cAMP in rat platelets. Biochem Biophys Res Commun 1992; 187: 1587–93.

    Article  PubMed  CAS  Google Scholar 

  6. Said SI, Mutt V. Polypeptide with broad biological activity. Science 1970; 169: 1217–8.

    Article  PubMed  CAS  Google Scholar 

  7. Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene related peptide is a potent vasodilator. Nature 1985; 313: 534–6.

    Article  Google Scholar 

  8. Kitamura K, Kangawa K, Kawamoto M, et al. AdrenomeduHin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553–60.

    Article  PubMed  CAS  Google Scholar 

  9. Ishiyama Y, Kitamura K, Ichiki Y, et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993; 241: 271–3.

    Article  PubMed  CAS  Google Scholar 

  10. Morris HR, Panico M, Etienne T, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1984; 308: 746–8.

    Article  PubMed  CAS  Google Scholar 

  11. Steenbergh PH, Hoeppener JWM, Zandberg J, et al. Second human calcitonin/CGRP gene. FEBS Lett 1985; 183: 403–7.

    Article  PubMed  CAS  Google Scholar 

  12. Cooper CJS, Willis AC, Clark A, et al. Purification and characterization of a peptide from amyloid rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987; 84: 8628–32.

    Article  PubMed  CAS  Google Scholar 

  13. Kitamura K, Kangawa K, Kojima M, et al. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett 1994; 338: 306–10.

    Article  PubMed  CAS  Google Scholar 

  14. Sakata J, Shimokubo K, Kitamura S, et al. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993; 195: 921–7.

    Article  PubMed  CAS  Google Scholar 

  15. Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989; 74: 1181–95.

    PubMed  CAS  Google Scholar 

  16. o’Halloran DJ, Bloom SR. Calcitonin gene related peptide: a major neuropeptide and the most powerful vasodilator known. BMJ 1991; 302: 739–40.

    Article  PubMed  Google Scholar 

  17. Nuki C, Kawasaki H, Kitamura K, et al. Vasodilator effect of adrenomedullin and calcitonin gene related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993; 196: 245–51.

    Article  PubMed  CAS  Google Scholar 

  18. DeWitt BJ, Cheng DY, Caminiti GN, et al. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the pulmonary vascular bed of the cat. Eur J Pharmacol 1994; 257: 303–6.

    Article  PubMed  CAS  Google Scholar 

  19. Ishizaka Y, Ishizaka Y, Tanaka M, et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994; 200: 642–6.

    Article  PubMed  CAS  Google Scholar 

  20. Eguchi S, Hirata Y, Kano H, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340: 226–30.

    Article  PubMed  CAS  Google Scholar 

  21. Ebara T, Miura K, Okumura M, et al. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994; 263: 69–73.

    Article  PubMed  CAS  Google Scholar 

  22. Takahashi H, Watanabe XT, Nishimura M, et al. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Hypertens 1994; 7: 478–82.

    PubMed  CAS  Google Scholar 

  23. Cooper GJS. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 1994; 15: 163–201.

    PubMed  CAS  Google Scholar 

  24. Kitamura K, Sakata J, Kangawa K, et al. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720–5.

    Article  PubMed  CAS  Google Scholar 

  25. Bradbury AF, Finnie MDA, Smyth DG. Mechanism of C terminal amide formation by pituitary enzymes.; Nature 1982; 298: 686–8.

    Article  PubMed  CAS  Google Scholar 

  26. Bradbury AF, Smyth DG. Modification of the N- and C-termini of bioactive peptides. In: Fricker LD, editor. Peptide biosynthesis and processing. Boca Raton: CRC Press, 1991: 231–50.

    Google Scholar 

  27. Ishimitsu T, Kojima M, Kangawa K, et al. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994; 203: 631–9.

    Article  PubMed  CAS  Google Scholar 

  28. Imagawa M, Chiu R, Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase. C and cAMR Cell 1987; 51: 251–60.

    Article  CAS  Google Scholar 

  29. Fink JS, Verhave M, Kasper S, et al. The CGTGA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc Natl Acad Sci USA 1988; 85: 6662–6.

    Article  PubMed  CAS  Google Scholar 

  30. Ichiki Y, Kitamura K, Kangawa K, et al. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6–10.

    Article  PubMed  CAS  Google Scholar 

  31. Sakata J, Shimokubo T, Kitamura K, et al. Distribution and characterization of immunoreactive adrenomedullin in rat tissue and plasma. FEBS Lett 1994; 352: 105–8.

    Article  PubMed  CAS  Google Scholar 

  32. Bean AJ, Zhang X, Hoekfelt T. Peptide secretion: what do we know? FASEB J 1994; 8: 630–8.

    PubMed  CAS  Google Scholar 

  33. Katoh F, Niina H, Kitumura K, et al. Ca2+dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine cultured adrenal medullary cells. FEBS Lett 1994; 348: 61–4.

    Article  PubMed  CAS  Google Scholar 

  34. Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160–6.

    Article  PubMed  CAS  Google Scholar 

  35. Sugo S, Minamino N, Shoji H, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun 1994; 203: 719–26.

    Article  PubMed  CAS  Google Scholar 

  36. Washimine H, Kitamura K, Ichiki Y, et al. Proadrenomedullin N-terminal 20 peptide (PAMP) in human tissue, plasma and urine. Biochem Biophys Res Commun 1994; 202: 1081–7.

    Article  PubMed  CAS  Google Scholar 

  37. Kitamura K, Kangawa K, Ishiyama Y, et al. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett 1994; 351: 35–7.

    Article  PubMed  CAS  Google Scholar 

  38. Katoh F, Kitamura K, Niina H, et al. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 1995; 64: 459–61.

    Article  PubMed  CAS  Google Scholar 

  39. Kitamura K, Ichiki Y, Tanaka M, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288–90.

    Article  PubMed  CAS  Google Scholar 

  40. Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158–61.

    Article  PubMed  CAS  Google Scholar 

  41. Tanaka M, Kitamura K, Ichiki Y, et al. Establishment of radioimmunoassay of adrenomedullin and plasma adrenomedullin levels in various diseases. Jpn Cire J 1994; 58: 494.

    Google Scholar 

  42. Nishikimi T, Kitamura K, Saito Y, et al. Clinical studies for the sites of the production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994; 24: 600–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kitamura, K., Kangawa, K., Matsuo, H. et al. Adrenomedullin. Drugs 49, 485–495 (1995). https://doi.org/10.2165/00003495-199549040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199549040-00001

Keywords

Navigation